Does AMIODARONE Cause Mobility decreased? 73 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 73 reports of Mobility decreased have been filed in association with AMIODARONE (Amiodarone Hydrochloride). This represents 0.3% of all adverse event reports for AMIODARONE.
73
Reports of Mobility decreased with AMIODARONE
0.3%
of all AMIODARONE reports
8
Deaths
46
Hospitalizations
How Dangerous Is Mobility decreased From AMIODARONE?
Of the 73 reports, 8 (11.0%) resulted in death, 46 (63.0%) required hospitalization, and 4 (5.5%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMIODARONE. However, 73 reports have been filed with the FAERS database.
What Other Side Effects Does AMIODARONE Cause?
Drug ineffective (2,223)
Dyspnoea (2,182)
Off label use (1,608)
Drug interaction (1,589)
Asthenia (1,452)
Interstitial lung disease (1,421)
Hyperthyroidism (1,410)
Fatigue (1,269)
Bradycardia (1,261)
Atrial fibrillation (1,211)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which AMIODARONE Alternatives Have Lower Mobility decreased Risk?
AMIODARONE vs AMISULPRIDE
AMIODARONE vs AMITRIPTYLINE
AMIODARONE vs AMITRIPTYLINE\PERPHENAZINE
AMIODARONE vs AMIVANTAMAB
AMIODARONE vs AMIVANTAMAB-VMJW